Caterpillar Inc CAT Secures Material Revenue Upside From AI Data Center Infrastructure Buildout Why Exponent EXPO cost structure is getting attention Exponent logs 19 pct EPS beat vs street estimates CIA Citizens posts 733 percent Q4 2025 EPS beat yet shares fall 204 percent on muted investor sentiment ICU SeaStar reports narrower than expected Q4 2025 loss shares fall 259 percent on cautious investor sentiment MuskAltman Trial Exposes Tech Industrys Darker Dynamics Key Lessons Stocks and Bonds Slide as Inflation Fears Return and Iran Tensions Persist Senti Biosciences SNTI Declines 490 Amid Market Weakness 20260513 Jim Cramer Warns Rising Bond Yields May Undermine Stock Rally and Rate Cut Hopes AI Demand Possibly Stressing Supplies of Lasers Fiber and Optical Components Bloom Energy Rallies on Hydrogen Momentum What Investors May Consider Abercrombie Fitch Shares Surge on Strong Earnings Marking 14th Consecutive Quarter of Sales Growth Markets Hottest Theme Investing in Everything AI Cant Replace The Rise of HALO Stocks Major Tech Companies Launch 125 Million Semiconductor Research Hub at UCLA LG Energy Solution Shares Surge on Major US Battery Storage Agreement QTTB Q1 2026 Earnings Narrowed Loss Drives Significant Stock Surge 374Water Inc SCWO Q1 2026 Earnings Net Loss Widens as Development Continues Without Revenue STNE Q1 2026 Earnings EPS Misses Estimates by 391 Stock Edges Higher Gemini Space Station Inc GEMI Q1 2026 Earnings Narrowed Loss Beats Estimates Despite Revenue Void HNI Q1 2026 Earnings EPS Beat Offers Profitability Signal Amid Quiet Revenue Disclosures EZRA Q1 2023 Earnings Massive EPS Beat Drives Stock Surge Bilibili BILI Slips Slightly as Technical Levels Tested Amid Sector Uncertainty Kandal M Venture FMFC Rallies 3 From Support Potential Breakout Above 041 in Sight Uxin UXIN Surges Over 6 as Stock Tests Key Resistance Near 250 Brookfield Business Partners BBU Slips 2 as Stock Nears Key Support Zone Aclaris Therapeutics ACRS Gains 244 as Buyers Defend Key Support Zone PreMarket News Roundup Key Themes and Market Context SHW Q1 2026 Earnings EPS Beats Estimates as Stock Edges Higher Taysha Gene Therapies TSHA Holds Steady Near Support as Biotech Sentiment Improves